Journal of Skin and Stem Cell

Published by: Kowsar

Signaling Molecules as Promising Drug Targets for the Treatment of Psoriasis

Zohreh Jadali 1 , 2 , *
Author Information
1 Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran
2 Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
Article information
  • Journal of Skin and Stem Cell: September 1, 2015, 2 (3); e31934
  • Published Online: September 29, 2015
  • Article Type: Letter
  • Received: July 29, 2015
  • Accepted: September 15, 2015
  • DOI: 10.17795/jssc31934

To Cite: Jadali Z. Signaling Molecules as Promising Drug Targets for the Treatment of Psoriasis, J Skin Stem Cell. 2015 ; 2(3):e31934. doi: 10.17795/jssc31934.

Copyright © 2015, Skin and Stem Cell Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
References
  • 1. Jadali Z, Eslami MB. T cell immune responses in psoriasis. Iran J Allergy Asthma Immunol. 2014; 13(4): 220-30[PubMed]
  • 2. Sehgal VN, Pandhi D, Khurana A. Biologics in dermatology: an integrated review. Indian J Dermatol. 2014; 59(5): 425-41[DOI][PubMed]
  • 3. Rongioletti F, Burlando M, Parodi A. Inflammatory/infectious cutaneous side effects of biological drugs in patients with psoriasis: a general review with personal data. G Ital Dermatol Venereol. 2014; 149(3): 311-6[PubMed]
  • 4. Hsu L, Armstrong AW. JAK inhibitors: treatment efficacy and safety profile in patients with psoriasis. J Immunol Res. 2014; 2014: 283617[DOI][PubMed]
  • 5. Belge K, Brück J, Ghoreschi K. Advances in treating psoriasis. F1000prime reports. 2014; 6
  • 6. Mocsai A, Kovacs L, Gergely P. What is the future of targeted therapy in rheumatology: biologics or small molecules? BMC Med. 2014; 12: 43[DOI][PubMed]
  • 7. Gadina M. Janus kinases: an ideal target for the treatment of autoimmune diseases. J Investig Dermatol Symp Proc. 2013; 16(1)-2[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments